Emory University School of Medicine, Renal Division, Atlanta, Georgia.
Kidney360. 2022 May 5;3(8):1359-1366. doi: 10.34067/KID.0001322022. eCollection 2022 Aug 25.
Rapid fluid removal during hemodialysis has been associated with increased mortality. The limit of ultrafiltration rate (UFR) monitored by the Centers for Medicare & Medicaid Services is 13 ml/kg per hour. It is not clear if the proportion of treatments with high UFR is associated with higher mortality. We examined the association of proportion of dialysis treatments with high UFR and mortality in end stage kidney failure patients receiving hemodialysis.
This was a retrospective study of incident patients initiating hemodialysis between January 1, 2010, and December 31, 2019, at Emory dialysis centers. The proportion of treatments with high UFR (>13 ml/kg per hour) per patient was calculated using data from the initial 3 months of dialysis therapy. Patients were categorized on the basis of quartiles of proportion of dialysis sessions with high UFR. Risk of death and survival probabilities were calculated and compared for all quartiles.
Of 1050 patients eligible, the median age was 59 years, 56% were men, and 91% were Black. The median UFR was 6.5 ml/kg per hour, and the proportion of sessions with high UFR was 5%. Thirty-one percent of patients never experienced high UFR. Being a man, younger age, shorter duration of hemodialysis sessions, lower weight, diabetic status, higher albumin, and history of heart failure were associated with a higher proportion of sessions with high UFR. Patients in the higher quartile (26% dialysis with high UFR, average UFR 9.8 ml/kg per hour, median survival of 5.6 years) had a higher risk of death (adjusted hazard ratio 1.54; 95% CI, 1.13 to 2.10) compared with those in the lower quartile (0% dialysis with high UFR, average UFR 4.7 ml/kg per hour, median survival 8.8 years).
Patients on hemodialysis who did not experience frequent episodes of elevated UFR during the first 3 months of their dialysis tenure had a significantly lower risk of death compared with patients with frequent episodes of high UFR.
血液透析过程中的快速液体清除与死亡率的增加有关。医疗保险和医疗补助服务中心监测的超滤率(UFR)限制为每小时 13 毫升/公斤。目前尚不清楚高 UFR 治疗比例是否与更高的死亡率有关。我们研究了接受血液透析的终末期肾衰竭患者中高 UFR 透析治疗比例与死亡率的关系。
这是一项回顾性研究,纳入了 2010 年 1 月 1 日至 2019 年 12 月 31 日期间在埃默里透析中心开始血液透析的患者。每位患者的高 UFR(>13 毫升/公斤/小时)治疗比例是根据透析治疗初始 3 个月的数据计算的。根据高 UFR 透析次数的四分位区间对患者进行分类。计算并比较了所有四分位数的死亡风险和生存概率。
在 1050 名符合条件的患者中,中位年龄为 59 岁,56%为男性,91%为黑人。中位 UFR 为 6.5 毫升/公斤/小时,高 UFR 治疗比例为 5%。31%的患者从未经历过高 UFR。男性、年龄较小、透析时间较短、体重较低、糖尿病状态、较高的白蛋白和心力衰竭史与高 UFR 治疗比例较高有关。处于较高四分位区间(26%的透析治疗中有高 UFR,平均 UFR 为 9.8 毫升/公斤/小时,中位生存时间为 5.6 年)的患者死亡风险更高(调整后的危险比为 1.54;95%置信区间,1.13 至 2.10),与处于较低四分位区间(0%的透析治疗中有高 UFR,平均 UFR 为 4.7 毫升/公斤/小时,中位生存时间为 8.8 年)的患者相比。
在透析开始的前 3 个月内未经历频繁高 UFR 发作的血液透析患者与经历频繁高 UFR 发作的患者相比,死亡风险显著降低。